Geoffrey Kline – Sponsored Projects — HSC

Geoffrey Kline public CV

View Scopus Profile

EmailGeoffrey.Klineunthscedu

h-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

1 Active
6 Finished

7 results

Active

A Long-term Outcomes Study to Assess Statin Residual Risk Reduction with EpaNova High Cardiovascular Risk Patients witgh Hypertriglyceridemia (STRENGTH)
Kline, G.
Astra Zeneca
8/06/15 → 30/06/24
Project: Research
Finished

A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with preserved Ejection Fraction (HFpEF).
Kline, G.
Boehringer Ingelheim International GmbH
25/04/17 → 24/04/21
Project: Research
A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with reduced Ejection Fraction (HFrEF).
Kline, G.
Boehringer Ingelheim International GmbH
25/04/17 → 24/04/21
Project: Research
PROMINENT- PEMAFIBRATE TO REDUCE CARDIOVASCULAR OUTCOMES BY REDUCING TRIGLYCERIDES IN PATIENTS WITH DIABETES
Kline, G.
Kowa Research Institute, Inc.
31/03/17 → 31/03/21
Project: Research
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effects of Bempedoic Acid (ETC-I 002) on the Occurrence of Major Cardiovascular Events in Patients with, or at High Risk For,Cardiovascular Disease Who Are Statin Intolerant
Kline, G.
Esperion Therapeutics, Inc.
13/02/17 → 13/02/21
Project: Research
A Phase 3 Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Long-term Safety and Tolerability of PF-04950615 in Subjects with Primary Hyperlipidemia or Mixed Dyslipdemia at Risk of Cardiovascular Events
Kline, G.
Pfizer, Inc.
17/03/15 → 31/03/20
Project: Research
A Readomized. Double-blind, Placebo-controlled,Parallel-group Studfy to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patgients Who Have Recently Experienced an Acute Coronary Syndrome
Kline, G.
Sanofi Pasteur, Inc.
31/01/13 → 30/01/20
Project: Research